{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:19:15Z","timestamp":1790983155212,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":221,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02723","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:49:39Z","timestamp":1786492179000},"page":"e02723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Rate-controlled intravenous voriconazole rapid desensitization in a patient with chronic pulmonary aspergillosis and triazole hypersensitivity"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-1474","authenticated-orcid":false,"given":"Eri","family":"Yasue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3764-4761","authenticated-orcid":false,"given":"Takunori","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koharu","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-7506","authenticated-orcid":false,"given":"Yoshifumi","family":"Kimizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2026.e02723_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/thorax-2024-222567","article-title":"British Thoracic Society Clinical Statement on Aspergillus-related chronic lung disease","volume":"80","author":"Brown","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.idcr.2026.e02723_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/1872213X13666190919162414","article-title":"Skin allergy to azole antifungal agents for systemic use: a review of the literature","volume":"13","author":"Calogiuri","year":"2019","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1016\/j.idcr.2026.e02723_bib3","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","article-title":"Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs","volume":"8","author":"Broyles","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.idcr.2026.e02723_bib4","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/jps.22109","article-title":"Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD)","volume":"99","author":"Luke","year":"2010","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.idcr.2026.e02723_bib5","unstructured":"Pfizer Inc. VFEND (voriconazole) prescribing information. Available from: https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=618. Accessed June 11, 2026."},{"key":"10.1016\/j.idcr.2026.e02723_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.12.1254","article-title":"Successful desensitization to voriconazole","volume":"131","author":"Zwiener","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.idcr.2026.e02723_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaip.2015.02.008","article-title":"Successful desensitization of voriconazole in an immunosuppressed pediatric patient","volume":"3","author":"Jean","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.idcr.2026.e02723_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13054-015-0753-8","article-title":"Evaluation of sulfobutylether-beta-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy","volume":"19","author":"Kiser","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.idcr.2026.e02723_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100640","article-title":"Standards for practical intravenous rapid drug desensitization & delabeling: a WAO committee statement","volume":"15","author":"Alvarez-Cuesta","year":"2022","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.idcr.2026.e02723_bib10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.anai.2025.07.018","article-title":"Update on desensitization to chemotherapeutics and biologicals","volume":"135","author":"Caiado","year":"2025","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:15:07Z","timestamp":1790723707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":10,"alternative-id":["S2214250926002362"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02723","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate-controlled intravenous voriconazole rapid desensitization in a patient with chronic pulmonary aspergillosis and triazole hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02723"}}